| Date |
Title |
| 06/20/12 |
AstraZeneca Completes Acquisition of Ardea Biosciences |
| 06/05/12 |
Ardea Biosciences Announces Expiration of HSR Waiting Period in Connection With Proposed Merger |
| 05/30/12 |
Ardea Biosciences Earns Milestone From Bayer HealthCare |
| 05/07/12 |
Ardea Biosciences Announces First Quarter 2012 Financial Results |
| 04/23/12 |
AstraZeneca to Acquire Ardea Biosciences for $1.26 Billion Including Lead Product Lesinurad in
Phase III Development for Gout |
| 03/09/12 |
Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year
2011 Financial Results |
| 02/29/12 |
Ardea Biosciences to Present at Upcoming Investor Conferences |
| 02/08/12 |
Ardea Biosciences to Present at Upcoming Investor Conferences |
| 02/06/12 |
Ardea Biosciences Announces Exercise in Full of Over-Allotment Option and Completion of Public
Offering of Common Stock |
| 02/01/12 |
Ardea Biosciences Prices Public Offering of Common Stock |
| 01/31/12 |
Ardea Biosciences Announces Proposed Public Offering of Common Stock |
